Go Deep
Biogen Inc.
Biogen Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,525 | 38.8 | 1.77 | 0.44 | 21,796.41 |
| Oct 2026 | 19,588 | 40.7 | 1.80 | 0.44 | 21,963.84 |
| Oct 2026 | 19,822 | 40.7 | 1.79 | 0.44 | 21,798.99 |
| Oct 2026 | 19,724 | 41.4 | 1.82 | 0.44 | 22,106.63 |
| Oct 2026 | 19,718 | 41.1 | 1.84 | 0.44 | 22,349.08 |
| Oct 2026 | 19,784 | 41.3 | 1.82 | 0.44 | 22,035.43 |
| Oct 2026 | 19,763 | 41.5 | 1.83 | 0.44 | 22,137.73 |
| Oct 2026 | 19,600 | 43.2 | 1.91 | 0.44 | 23,049.86 |
| Oct 2026 | 19,652 | 42.8 | 1.89 | 0.44 | 22,792.41 |
| Oct 2026 | 19,535 | 45.1 | 1.99 | 0.44 | 23,960.17 |
| Oct 2026 | 19,610 | 44.5 | 1.97 | 0.44 | 23,760.94 |
Biogen Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,736,000,000.0 | 2,477,800,000.0 | 2,279,400,000.0 | 2,534,700,000.0 |
| Net Profit | 97,500,000.0 | 319,500,000.0 | -48,900,000.0 | 466,500,000.0 |
| EPS | 0.7 | 2.2 | -0.3 | 3.2 |
Biogen Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 9,890,600,000.0 | 9,675,900,000.0 | 9,835,600,000.0 | 10,173,400,000.0 | — |
| Net Profit | 1,292,900,000.0 | 1,632,200,000.0 | 1,161,100,000.0 | 3,046,900,000.0 | — |
| EPS | 8.8 | 11.2 | 8.0 | 21.0 | — |
Biogen Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 29,439,500,000.0 | 28,049,300,000.0 | 26,844,800,000.0 | 24,554,100,000.0 | — |
| Total Liabilities | 11,182,700,000.0 | 11,333,300,000.0 | 12,045,400,000.0 | 11,165,700,000.0 | — |
| Total Equity | 18,256,800,000.0 | 16,716,000,000.0 | 14,799,400,000.0 | 13,397,900,000.0 | — |
Owes vs Owns
Biogen Inc. owed $0.41 for every $1 it owned in Jun 2026, down from $0.45 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.41× | 0.38× | 0.40× | 0.45× | 0.45× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Biogen Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 13.0%Receivables 6.3%Inventory 7.4%Fixed assets (tangible) 11.3%Intangible assets 53.2%Long-term investments 1.5%Other assets 7.4%
How it's funded — Dec 2025
Long-term debt 21.4%Payables 1.5%Other liabilities 15.2%Shareholders' equity 62.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3,815.7 | 2,375.0 | 1,049.9 | 4,892.8 |
| Receivables | 1,867.0 | 1,868.8 | 2,100.0 | 2,136.4 |
| Inventory | 2,168.1 | 2,460.5 | 2,527.4 | 1,344.4 |
| Fixed assets (tangible) | 3,320.8 | 3,537.7 | 3,729.7 | 3,702.5 |
| Intangible assets | 15,669.6 | 16,170.1 | 14,582.2 | 7,599.1 |
| Long-term investments | 431.9 | 0.0 | 0.0 | 705.7 |
| Other assets | 2,166.4 | 1,637.2 | 2,855.6 | 4,173.2 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 1,748.6 | 150.0 | 0.0 |
| Long-term debt | 6,286.8 | 4,547.2 | 6,788.2 | 6,281.0 |
| Payables | 432.0 | 424.2 | 403.3 | 491.5 |
| Other liabilities | 4,463.9 | 4,613.3 | 4,703.9 | 4,393.2 |
| Shareholders' equity | 18,256.8 | 16,716.0 | 14,799.4 | 13,388.4 |
| Net tangible assets | 2,587.2 | 545.9 | 217.2 | 5,798.8 |
Biogen Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 2,204,600,000.0 | 2,875,500,000.0 | 1,547,200,000.0 | 1,384,300,000.0 | — |
| Investing Activities | -1,371,100,000.0 | -799,200,000.0 | -4,101,000,000.0 | 1,576,600,000.0 | — |
| Financing Activities | -301,900,000.0 | -683,500,000.0 | 149,300,000.0 | -1,747,300,000.0 | — |